We are live on ! Find out more
ICCM icon

IceCure Medical
ICCM

17 hedge funds and large institutions have $977K invested in IceCure Medical in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more capital invested

Capital invested by funds: $319K → $977K (+$658K)

0.12% more ownership

Funds ownership: 0.03% → 0.15% (+0.12%)

6% less funds holding

Funds holding: 18 → 17 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.65M
2
WAM
Warberg Asset Management
Illinois
+$39.9K
3
UBS Group
UBS Group
Switzerland
+$37.8K
4
HF
HRT Financial
New York
+$19.6K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$18.3K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$66.9K
2
VF
Virtu Financial
New York
-$39K
3
LPL Financial
LPL Financial
California
-$14.3K
4
TSS
Two Sigma Securities
New York
-$13.6K
5
Bank of America
Bank of America
North Carolina
-$614
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$816K +$1.65M +90,400 New
UBS Group
2
UBS Group
Switzerland
$46.4K +$37.8K +2,068 +67%
CIA
3
Concurrent Investment Advisors
Florida
$23.6K – – –
WAM
4
Warberg Asset Management
Illinois
$19.7K +$39.9K +2,186 New
HF
5
HRT Financial
New York
$14K +$19.6K +1,075 +210%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$12.2K – – –
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$9.03K +$18.3K +1,000 New
GCM
8
Gunderson Capital Management
South Carolina
$6.02K – – –
Morgan Stanley
9
Morgan Stanley
New York
$5.12K +$7.31K +400 +240%
KFG
10
Kingdom Financial Group
Arizona
$4.82K +$9.74K +533 New
LAS
11
Lloyd Advisory Services
Georgia
$4.82K +$9.74K +533 New
FIA
12
Foundations Investment Advisors
Arizona
$4.51K – – –
WSCM
13
Wellington Shields Capital Management
New York
$4.51K – – –
Janney Montgomery Scott
14
Janney Montgomery Scott
Pennsylvania
$3K – – –
JP Morgan Chase
15
JP Morgan Chase
New York
$1.67K – – –
AW
16
Avion Wealth
Texas
$1K – – –
BCWM
17
Bartlett & Co Wealth Management
Ohio
$73 – – –
SS
18
SBI Securities
Japan
$3 – – –
Jane Street
19
Jane Street
New York
– -$66.9K -3,655 Closed
VF
20
Virtu Financial
New York
– -$39K -2,151 Closed
LPL Financial
21
LPL Financial
California
– -$14.3K -779 Closed
TSS
22
Two Sigma Securities
New York
– -$13.6K -743 Closed
Bank of America
23
Bank of America
North Carolina
– -$614 -34 Closed
Northwestern Mutual Wealth Management
24
Northwestern Mutual Wealth Management
Wisconsin
– -$305 -17 Closed

ICCM Hedge Fund Activity: Q1 2026 in Review

17 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2026, worth a combined $977K — up 207% from $319K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ICCM and 5 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.65M. The largest seller was Jane Street, exiting entirely with an estimated $66.9K sold.

  • 17 institutional investors held IceCure Medical (ICCM) as of Q1 2026, down from 18 in Q4 2025.
  • Funds reported $977K of IceCure Medical stock for Q1 2026, up 207% quarter-over-quarter.
  • 5 funds opened new IceCure Medical positions in Q1 2026 and 6 closed out, a net change of -1 holder.
  • The largest IceCure Medical buyer in Q1 2026 was Armistice Capital, an estimated $1.65M added.
  • The largest IceCure Medical seller in Q1 2026 was Jane Street, an estimated $66.9K sold.

Based on aggregated 13F filings for Q1 2026.